Similar articles

• Acute myeloblastic leukemia in adults.

  Kasthuri AS, Jaiprakash MP, Anand KP, Kumar R. Kasthuri AS, et al. J Assoc Physicians India. 1995 Feb;43(2):108-10. J Assoc Physicians India. 1995. PMID: 9282674 No abstract available.
• Results of the Italian AIEOP/LAM 8204 study for the treatment of childhood AML: an update.

  Amadori S, Mandelli F, Ceci A, Comelli A, Madon E, Masera G, Nespoli L, Paolucci G, Zanesco L, Defazio D. Amadori S, et al. Bone Marrow Transplant. 1989 Jan;4 Suppl 1:114-5. Bone Marrow Transplant. 1989. PMID: 2653484 Clinical Trial. No abstract available.
• Combination chemotherapy with DATV regimen in treatment of adult acute nonlymphocytic leukemia.

  Lou FD, Zhou Q, Liu HC, Meng FY, Wang YZ. Lou FD, et al. Chin Med J (Engl). 1993 Nov;106(11):876-8. Chin Med J (Engl). 1993. PMID: 8143502 No abstract available.
• Improved cure rate by very early intensification combined with prolonged maintenance chemotherapy in patients with acute myeloid leukemia: data from the AML Cooperative Group.

  Büchner T, Hiddemann W, Löffler G, Gassmann W, Maschmeyer G, Heit W, Hossfeld D, Weh H, Ludwig WD, Thiel E, et al. Büchner T, et al. Semin Hematol. 1991 Jul;28(3 Suppl 4):76-9. Semin Hematol. 1991. PMID: 1780757 Review. No abstract available.
• Down syndrome and acute myeloid leukemia. Lessons learned from experience with high-dose Ara-C containing regimens.

  Ravindranath Y, Taub JW. Ravindranath Y, et al. Adv Exp Med Biol. 1999;457:409-14. Adv Exp Med Biol. 1999. PMID: 10500816 Review. No abstract available.